Out-of-pocket spending on insulin among people with private insurance
(By Krutika Amin, Gary Claxton, Matthew Rae, and Cynthia Cox for Kaiser Family Foundation published March 24, 2022) The Build
Read More
Part D/Prescription Drugs
The FDA is expected to authorize 2nd boosters for people 50 and up
(By Rob Stein and Jane Greenhalgh for NPR) Anyone 50 years and older could soon be eligible for a second
Read MoreTips on reviewing your Medicare Advantage plan
Many people switch to Medicare Advantage during the fall Medicare Annual Enrollment Period, not fully understanding how the plans work.
Read MoreDon’t wait: Medicare Advantage Open Enrollment ends March 31
(Source – www.medicare.gov/blog) Did you know that if you’re unhappy with your Medicare Advantage Plan (Medicare Part C), you have
Read MorePayer organizations respond to CMS’ Medicare Advantage, Part D proposed rule
(By Georgina Gonzalez for Becker’s Hospital Review) America’s Health Insurance Plans and the Alliance of Community Health Plans have commented
Read MoreWomen see more adverse events with chemotherapy and newer cancer treatments, study finds
(By Marcus A. Banks for STAT) When Crystal Ortner was diagnosed with stage 4 colon cancer, her doctors decided to
Read MorePatients Divided Over Alzheimer’s Drug: Is It a ‘Risk I’m Willing to Take’ or Just a ‘Magic Pill’?
(By Judith Graham for Kaiser Health News) If you listen to the nation’s largest Alzheimer’s disease advocacy organizations, you might
Read MoreSacklers agree to $6 billion Purdue bankruptcy settlement over opioid crisis
(By Ed Silverman for STAT) The Sackler family members who own Purdue Pharma have agreed to pay up to $6
Read More$35 Insulin Cap Is Welcome, Popular, and Bipartisan. But Congress May Not Pass It Anyway
(By Michael McAuliff for Kaiser Health News) Democrats in the Senate are primed this month to make their first attempt
Read MorePrices Increased Faster Than Inflation for Half of all Drugs Covered by Medicare in 2020
(By Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published February 25, 2022) While momentum to enact the Build
Read More